2017 Vol.35, N°4 - Suppl.106 - Table of contents
Scleroderma 2017
10th Annual Supplement on Systemic Sclerosis
Guest Editor: S. Bombardieri
One year in review
CER10809
2017,35,4,Suppl.106
Pg. 0003-0020
Free to view
One year in review 2017: systemic sclerosis
S. Barsotti, C. Bruni, M. Orlandi, A. Della Rossa, E. Marasco, V. Codullo, S. Guiducci
S. Barsotti, C. Bruni, M. Orlandi, A. Della Rossa, E. Marasco, V. Codullo, S. Guiducci
Aetiopathogenesis
CER9845
2017,35,4,Suppl.106
Pg. 0021-0030
Free to view
Exosomes isolated from serum of systemic sclerosis patients display alterations in their content of profibrotic and antifibrotic microRNA and induce a profibrotic phenotype in cultured normal dermal fibroblasts
P.J. Wermuth, S. Piera-Velazquez, S.A. Jimenez
P.J. Wermuth, S. Piera-Velazquez, S.A. Jimenez
CER9910
2017,35,4,Suppl.106
Pg. 0031-0034
Increased immunoreactivity against human cytomegalovirus UL83 in systemic sclerosis
E. Marou, C. Liaskos, G. Efthymiou, E. Dardiotis, A. Daponte, T. Scheper, W. Meyer, G. Hadjigeorgiou, D.P. Bogdanos, L.I. Sakkas
E. Marou, C. Liaskos, G. Efthymiou, E. Dardiotis, A. Daponte, T. Scheper, W. Meyer, G. Hadjigeorgiou, D.P. Bogdanos, L.I. Sakkas
CER9967
2017,35,4,Suppl.106
Pg. 0035-0039
Dabigatran aggravates topoisomerase I peptide-loaded dendritic cells-induced lung and skin fibrosis
H. Mehta, S. Mashiko, P.-O. Goulet, J. Desjardins, G. Pérez, M. Koenig, J.-L. Senécal, M. Sarfati
H. Mehta, S. Mashiko, P.-O. Goulet, J. Desjardins, G. Pérez, M. Koenig, J.-L. Senécal, M. Sarfati
Clinical aspects
CER9503
2017,35,4,Suppl.106
Pg. 0040-0047
Changes in the pattern of death of 987 patients with systemic sclerosis from 1990 to 2009 from the nationwide Spanish Scleroderma Registry (RESCLE)
M. Rubio-Rivas, C.P. Simeón-Aznar, C. Velasco, B. Marí-Alfonso, G. Espinosa, X. Corbella, D. Colunga Argüelles, M.V. Egurbide-Arberas, N. Ortego-Centeno, J.A. Vargas-Hitos, M. Freire, J.J. Ríos-Blanco, L. Trapiella-Martínez, M. Rodríguez-Carballeira, V. Fonollosa-Pla
on behalf of RESCLE investigators, Autoimmune Diseases Study Group (GEAS)
M. Rubio-Rivas, C.P. Simeón-Aznar, C. Velasco, B. Marí-Alfonso, G. Espinosa, X. Corbella, D. Colunga Argüelles, M.V. Egurbide-Arberas, N. Ortego-Centeno, J.A. Vargas-Hitos, M. Freire, J.J. Ríos-Blanco, L. Trapiella-Martínez, M. Rodríguez-Carballeira, V. Fonollosa-Pla
on behalf of RESCLE investigators, Autoimmune Diseases Study Group (GEAS)
CER9777
2017,35,4,Suppl.106
Pg. 0048-0055
Three-year trajectories of disability and fatigue in systemic sclerosis: a cohort study
L.M. Willems, L. Kwakkenbos, M.C. Vonk, F.H. Van Den Hoogen, T.P. Vliet Vlieland, C.H. Van Den Ende
L.M. Willems, L. Kwakkenbos, M.C. Vonk, F.H. Van Den Hoogen, T.P. Vliet Vlieland, C.H. Van Den Ende
CER9924
2017,35,4,Suppl.106
Pg. 0056-0060
Relationship between calcium channel blockers and skin fibrosis in patients with systemic sclerosis
G. Li, J.D. Adachi, J. Cheng, L. Thabane, M. Hudson, M.J. Fritzler, S. Lorenzi, M. Baron, M. Larché
for the Canadian Scleroderma Research Group.
G. Li, J.D. Adachi, J. Cheng, L. Thabane, M. Hudson, M.J. Fritzler, S. Lorenzi, M. Baron, M. Larché
for the Canadian Scleroderma Research Group.
CER10142
2017,35,4,Suppl.106
Pg. 0061-0070
The presence of small joint contractures is a risk factor for survival in 439 patients with systemic sclerosis.
G. Nagy, T. Minier, C. Varjú, R. Faludi, K.T. Kovács, V. Lóránd, V. Hermann, L. Czirják, G. Kumánovics
G. Nagy, T. Minier, C. Varjú, R. Faludi, K.T. Kovács, V. Lóránd, V. Hermann, L. Czirják, G. Kumánovics
CER10201
2017,35,4,Suppl.106
Pg. 0071-0074
Free to view
Evaluation of cancer-associated myositis and scleroderma autoantibodies in breast cancer patients without rheumatic disease
A.A. Shah, A. Rosen, L.K. Hummers, B.J. May, A. Kaushiva, R.B. Roden, D.K. Armstrong, F.M. Wigley, L. Casciola-Rosen, K. Visvanathan
A.A. Shah, A. Rosen, L.K. Hummers, B.J. May, A. Kaushiva, R.B. Roden, D.K. Armstrong, F.M. Wigley, L. Casciola-Rosen, K. Visvanathan
CER10460
2017,35,4,Suppl.106
Pg. 0075-0081
Free to view
Design of a randomised, placebo-controlled clinical trial of nintedanib in patients with systemic sclerosis-associated interstitial lung disease (SENSCIS™)
O. Distler, K.K. Brown, J.H. Distler, S. Assassi, T.M. Maher, V. Cottin, J. Varga, C. Coeck, M. Gahlemann, W. Sauter, H. Schmidt, K.B. Highland
on behalf of the SENSCIS™ trial investigators
O. Distler, K.K. Brown, J.H. Distler, S. Assassi, T.M. Maher, V. Cottin, J. Varga, C. Coeck, M. Gahlemann, W. Sauter, H. Schmidt, K.B. Highland
on behalf of the SENSCIS™ trial investigators
CER10368
2017,35,4,Suppl.106
Pg. 0082-0085
Severe oesophageal disease and its associations with systemic sclerosis
G.P. Karamanolis, K. Denaxas, S. Panopoulos, K.-V. Bournia, A. Zorbala, D. Kamberoglou, D. Schizas, S.D. Ladas, P.P. Sfikakis
G.P. Karamanolis, K. Denaxas, S. Panopoulos, K.-V. Bournia, A. Zorbala, D. Kamberoglou, D. Schizas, S.D. Ladas, P.P. Sfikakis
CER10649
2017,35,4,Suppl.106
Pg. 0086-0088
Oesophageal disease in systemic sclerosis: does heritability play a role?
T.M. Frech, L. Fakoya, A.J. Gawron, J. Wong, M.B. Scholand, A. Sawitzke, K. Peterson
T.M. Frech, L. Fakoya, A.J. Gawron, J. Wong, M.B. Scholand, A. Sawitzke, K. Peterson
CER10557
2017,35,4,Suppl.106
Pg. 0089-0097
Free to view
Clinical and epidemiological differences between men and women with systemic sclerosis: a study in a Spanish systemic sclerosis cohort and literature review
M. Freire, A. Rivera, B. Sopeña, C. Tolosa Vilella, A. Guillén Del Castillo, D. Colunga Argüelles, J.L. Callejas Rubio, M. Rubio Rivas, L. Trapiella Martínez, J.A. Todolí Parra, M. Rodríguez Carballeira, N. Iniesta Arandia, F.J. García Hernández, M.V. Egurbide Arberas, L. Sáez Comet, J.A. Vargas Hitos, J.J. Ríos Blanco, A. Marín Ballvé, X. Pla Salas, A.B. Madroñero Vuelta, M. Ruiz Muñoz, V. Fonollosa Pla, C.P. Simeón Aznar
on behalf of RESCLE investigators, Autoimmune Diseases Study Group (GEAS)
M. Freire, A. Rivera, B. Sopeña, C. Tolosa Vilella, A. Guillén Del Castillo, D. Colunga Argüelles, J.L. Callejas Rubio, M. Rubio Rivas, L. Trapiella Martínez, J.A. Todolí Parra, M. Rodríguez Carballeira, N. Iniesta Arandia, F.J. García Hernández, M.V. Egurbide Arberas, L. Sáez Comet, J.A. Vargas Hitos, J.J. Ríos Blanco, A. Marín Ballvé, X. Pla Salas, A.B. Madroñero Vuelta, M. Ruiz Muñoz, V. Fonollosa Pla, C.P. Simeón Aznar
on behalf of RESCLE investigators, Autoimmune Diseases Study Group (GEAS)
CER10639
2017,35,4,Suppl.106
Pg. 0098-0105
Free to view
Influence of antibody profile in clinical features and prognosis in a cohort of Spanish patients with systemic sclerosis
N. Iniesta Arandia, C.P. Simeón-Aznar, A. Guillén Del Castillo, D. Colunga Argüelles, M. Rubio-Rivas, L. Trapiella Martínez, F.J. García Hernández, L. Sáez Comet, M.V. Egurbide Arberas, N. Ortego-Centeno, M. Freire, B. Marí Alfonso, J.A. Vargas Hitos, J.J. Ríos Blanco, J.A. Todolí Parra, M. Rodríguez-Carballeira, A. Marín Ballvé, A.J. Chamorro Fernández, X. Pla Salas, A.B. Madroñero Vuelta, M. Ruiz Muñoz, V. Fonollosa Pla, G. Espinosa
on behalf of RESCLE investigators, Autoimmune Diseases Study Group (GEAS).
N. Iniesta Arandia, C.P. Simeón-Aznar, A. Guillén Del Castillo, D. Colunga Argüelles, M. Rubio-Rivas, L. Trapiella Martínez, F.J. García Hernández, L. Sáez Comet, M.V. Egurbide Arberas, N. Ortego-Centeno, M. Freire, B. Marí Alfonso, J.A. Vargas Hitos, J.J. Ríos Blanco, J.A. Todolí Parra, M. Rodríguez-Carballeira, A. Marín Ballvé, A.J. Chamorro Fernández, X. Pla Salas, A.B. Madroñero Vuelta, M. Ruiz Muñoz, V. Fonollosa Pla, G. Espinosa
on behalf of RESCLE investigators, Autoimmune Diseases Study Group (GEAS).
Diagnosis
CER9389
2017,35,4,Suppl.106
Pg. 0106-0113
Utility of B-type natriuretic peptides in the assessment of patients with systemic sclerosis-associated pulmonary hypertension in the PHAROS registry
L. Chung, R.M. Fairchild, D.E. Furst, S. Li, F. Alkassab, M.B. Bolster, M.E. Csuka, C.T. Derk, R.T. Domsic, A. Fischer, T.M. Frech, M. Gomberg-Maitland, J.K. Gordon, M. Hinchcliff, V. Hsu, L.K. Hummers, D. Khanna, T.A.J. Medsger, J.A. Molitor, I.R. Preston, E. Schiopu, L. Shapiro, F. Hant, R. Silver, R. Simms, J. Varga, V.D. Steen, R.T. Zamanian
L. Chung, R.M. Fairchild, D.E. Furst, S. Li, F. Alkassab, M.B. Bolster, M.E. Csuka, C.T. Derk, R.T. Domsic, A. Fischer, T.M. Frech, M. Gomberg-Maitland, J.K. Gordon, M. Hinchcliff, V. Hsu, L.K. Hummers, D. Khanna, T.A.J. Medsger, J.A. Molitor, I.R. Preston, E. Schiopu, L. Shapiro, F. Hant, R. Silver, R. Simms, J. Varga, V.D. Steen, R.T. Zamanian
CER9677
2017,35,4,Suppl.106
Pg. 0114-0121
Clinical determinants of elevated systolic pulmonary artery pressure measured by transthoracic Doppler echocardiography in early systemic sclerosis
P.E. Carreira, L. Carmona, B.E. Joven, E. Loza, J.L. Andreu, G. Riemekasten, S. Vettori, Y. Allanore, A. Balbir-Gurman, P. Airò, U.A. Walker, N. Damjanov, L.P. Ananieva, S. Rednic, L. Czirják, O. Distler, D. Farge, R. Hesselstrand, A. Corrado, P. Caramaschi, M. Tikly, M. Matucci-Cerinic
and EUSTAR co-authors
P.E. Carreira, L. Carmona, B.E. Joven, E. Loza, J.L. Andreu, G. Riemekasten, S. Vettori, Y. Allanore, A. Balbir-Gurman, P. Airò, U.A. Walker, N. Damjanov, L.P. Ananieva, S. Rednic, L. Czirják, O. Distler, D. Farge, R. Hesselstrand, A. Corrado, P. Caramaschi, M. Tikly, M. Matucci-Cerinic
and EUSTAR co-authors
CER9886
2017,35,4,Suppl.106
Pg. 0122-0129
Six-minute walk test in or out in evaluation of systemic sclerosis patients?
E. Vandecasteele, K. Thevissen, K. Melsens, F. De Keyser, M. De Pauw, E. Deschepper, S. Decuman, Y. Piette, G. Brusselle, V. Smith
E. Vandecasteele, K. Thevissen, K. Melsens, F. De Keyser, M. De Pauw, E. Deschepper, S. Decuman, Y. Piette, G. Brusselle, V. Smith
CER10311
2017,35,4,Suppl.106
Pg. 0130-0137
Validity of the Workers Productivity and Activity Impairment Questionnaire: Specific Health Problem (WPAI:SHP) in patients with systemic sclerosis
K. Morrisroe, W. Stevens, M. Huq, J. Sahhar, G.-S. Ngian, J. Zochling, J. Roddy, S.M. Proudman, M. Nikpour
the Australian Scleroderma Interest Group (ASIG)
K. Morrisroe, W. Stevens, M. Huq, J. Sahhar, G.-S. Ngian, J. Zochling, J. Roddy, S.M. Proudman, M. Nikpour
the Australian Scleroderma Interest Group (ASIG)
CER10355
2017,35,4,Suppl.106
Pg. 0138-0143
The use of hand perfusion scintigraphy to assess Raynaud’s phenomenon associated with hand-arm vibration syndrome
K.-A. Lee, H.W. Chung, S.-H. Lee, H.-R. Kim
K.-A. Lee, H.W. Chung, S.-H. Lee, H.-R. Kim
CER10174
2017,35,4,Suppl.106
Pg. 0144-0150
Resistin: a possible biomarker of organ involvement in systemic sclerosis patients?
K. Sawicka, M. Michalska-Jakubus, M. Kowal, E. Potembska, D. Krasowska
K. Sawicka, M. Michalska-Jakubus, M. Kowal, E. Potembska, D. Krasowska
Treatment
CER10087
2017,35,4,Suppl.106
Pg. 0151-0158
Free to view
Evaluation of the effect of sildenafil on the microvascular blood flow in patients with systemic sclerosis: a randomised, double-blind, placebo-controlled study
F.V. Andrigueti, P.C. Ebbing, M.I. Arismendi, C. Kayser
F.V. Andrigueti, P.C. Ebbing, M.I. Arismendi, C. Kayser
CER10068
2017,35,4,Suppl.106
Pg. 0159-0166
Efficacy of intensive hand physical therapy in patients with systemic sclerosis
J. Horváth, Z. Bálint, E. Szép, A. Deiszinger, T. Minier, N. Farkas, E. Török, É. Horváthné Papp, D. Komjáti, Z. Mándó, L. Czirják, C. Varjú
J. Horváth, Z. Bálint, E. Szép, A. Deiszinger, T. Minier, N. Farkas, E. Török, É. Horváthné Papp, D. Komjáti, Z. Mándó, L. Czirják, C. Varjú
CER10403
2017,35,4,Suppl.106
Pg. 0167-0172
Acute oral tetrahydrobiopterin administration ameliorates endothelial dysfunction in systemic sclerosis
D.R. Machin, H.L. Clifton, R.S. Richardson, D.W. Wray, A.J. Donato, T.M. Frech
D.R. Machin, H.L. Clifton, R.S. Richardson, D.W. Wray, A.J. Donato, T.M. Frech
CER10391
2017,35,4,Suppl.106
Pg. 0173-0178
Free to view
A novel iloprost administration method with portable syringe pump for the treatment of acral ulcers and Raynaud's phenomenon in systemic sclerosis patients. A pilot study (ILOPORTA)
P. Fraticelli, G.P. Martino, M. Murri, M. Mattioli, A. Gabrielli
P. Fraticelli, G.P. Martino, M. Murri, M. Mattioli, A. Gabrielli
CER10476
2017,35,4,Suppl.106
Pg. 0179-0183
Long-term treatment of scleroderma-related digital ulcers with iloprost: a cohort study
M. Colaci, F. Lumetti, D. Giuggioli, S. Guiducci, S. Bellando-Randone, G. Fiori, M. Matucci-Cerinic, C. Ferri
M. Colaci, F. Lumetti, D. Giuggioli, S. Guiducci, S. Bellando-Randone, G. Fiori, M. Matucci-Cerinic, C. Ferri
Review
CER9760
2017,35,4,Suppl.106
Pg. 0184-0192
Free to view
Patient participation in patient-reported outcome instrument development in systemic sclerosis
J.D. Pauling, T.M. Frech, R.T. Domsic, M. Hudson
J.D. Pauling, T.M. Frech, R.T. Domsic, M. Hudson
CER9691
2017,35,4,Suppl.106
Pg. 0193-0197
Fatigue in patients with systemic sclerosis and hypothyroidism. A review of the literature and report of our experience
A. Antonelli, P. Fallahi, F. Di Bari, D. Giuggioli, S.M. Ferrari, C. Ferri
A. Antonelli, P. Fallahi, F. Di Bari, D. Giuggioli, S.M. Ferrari, C. Ferri
CER10242
2017,35,4,Suppl.106
Pg. 0198-0207
Free to view
Autologous stem cell transplantation in systemic sclerosis: a systematic review
L. Host, M. Nikpour, A. Calderone, P. Cannell, J. Roddy
L. Host, M. Nikpour, A. Calderone, P. Cannell, J. Roddy
Case Reports
CER10014
2017,35,4,Suppl.106
Pg. 0208-0210
Treatment of psoriasis with ustekinumab improved skin tightening in systemic sclerosis
A. Ichihara, M. Jinnin, H. Ihn
A. Ichihara, M. Jinnin, H. Ihn
Paediatric Rheumatology
CER10478
2017,35,4,Suppl.106
Pg. 0211-0213
Tocilizumab in two children with pansclerotic morphoea: a hopeful therapy for refractory cases?
G. Martini, S. Campus, R. Bernd, G. Boscarol, A. Meneghel, F. Zulian
G. Martini, S. Campus, R. Bernd, G. Boscarol, A. Meneghel, F. Zulian
Letters to the Editor
CER9881
2017,35,4,Suppl.106
Pg. 0214-0215
Free to view
Successful treatment of a refractory dysbiotic intestinal pseudo-obstruction in a patient with systemic sclerosis-polymyositis overlap syndrome by intravenous immunoglobulin administration possibly related to gut flora normalisation
R. Kamei, T. Yamaoka, K. Ikinaga, H. Murota, K. Shimizu, I. Katayama
R. Kamei, T. Yamaoka, K. Ikinaga, H. Murota, K. Shimizu, I. Katayama
CER10080
2017,35,4,Suppl.106
Pg. 0216
Free to view
Moyamoya disease and systemic sclerosis (MoSys syndrome): a combination of two rare entities: comment to the authors
E. De Langhe, J. Lenaerts, P. Demaerel, R. Lemmens
E. De Langhe, J. Lenaerts, P. Demaerel, R. Lemmens
CER10380
2017,35,4,Suppl.106
Pg. 0217
Free to view
Reply to: Moyamoya disease and systemic sclerosis (MoSys syndrome): a combination of two rare entities: comment to the authors
F. Wegner, U. Müller-Ladner, F.M. Meier
F. Wegner, U. Müller-Ladner, F.M. Meier
CER9741
2017,35,4,Suppl.106
Pg. 0218-0219
Free to view
A pilot study using high-frequency ultrasound to measure digital ulcers: a possible outcome measure in systemic sclerosis clinical trials?
M. Hughes, T. Moore, J. Manning, G. Dinsdale, A.L. Herrick, A. Murray
M. Hughes, T. Moore, J. Manning, G. Dinsdale, A.L. Herrick, A. Murray
CER10306
2017,35,4,Suppl.106
Pg. 0220
Free to view
Serum thyroxine levels are associated with increased systolic pulmonary arterial pressure in systemic sclerosis
G.L. Bagnato, R.M. Ruggeri, R. Certo, M. Cusmà Piccione, S. Carerj, W.N. Roberts
G.L. Bagnato, R.M. Ruggeri, R. Certo, M. Cusmà Piccione, S. Carerj, W.N. Roberts
CER10342
2017,35,4,Suppl.106
Pg. 0221-0222
Free to view
Significance of pentraxin-3 in patients with juvenile scleroderma
A. Adrovic, S. Sahin, K. Barut, S. Durmus, H. Uzun, O. Kasapcopur
A. Adrovic, S. Sahin, K. Barut, S. Durmus, H. Uzun, O. Kasapcopur
CER10737
2017,35,4,Suppl.106
Pg. 0223-0224
Free to view
Serum chemerin in systemic sclerosis: a novel marker of early diffuse disease?
C.B. Chighizola, E. Raschi, D. Privitera, A.F. Luppino, C. Artusi, T. Schioppo, C. Mastaglio, F. Ingegnoli, M.O. Borghi, P.L. Meroni
C.B. Chighizola, E. Raschi, D. Privitera, A.F. Luppino, C. Artusi, T. Schioppo, C. Mastaglio, F. Ingegnoli, M.O. Borghi, P.L. Meroni